299 related articles for article (PubMed ID: 20586713)
1. Iloperidone for schizophrenia.
Rado J; Janicak PG
Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
[TBL] [Abstract][Full Text] [Related]
2. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
3. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
4. Iloperidone for the treatment of schizophrenia.
Marino J; Caballero J
Ann Pharmacother; 2010 May; 44(5):863-70. PubMed ID: 20388862
[TBL] [Abstract][Full Text] [Related]
5. [Risperidone].
Zolk O; Thürauf N
Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
[No Abstract] [Full Text] [Related]
6. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
7. Iloperidone for the treatment of schizophrenia: an updated clinical review.
Weiden PJ
Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):34-44. PubMed ID: 22453868
[TBL] [Abstract][Full Text] [Related]
8. Iloperidone: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, regulatory affairs, and an opinion.
Citrome L
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1551-64. PubMed ID: 21034370
[TBL] [Abstract][Full Text] [Related]
9. Risperidone: clinical issues in treatment.
Littrell K; Schultz RE
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):47-9. PubMed ID: 7519677
[No Abstract] [Full Text] [Related]
10. Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2010 May; 64(6):707-18. PubMed ID: 20201991
[TBL] [Abstract][Full Text] [Related]
11. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
Albers LJ; Musenga A; Raggi MA
Expert Opin Investig Drugs; 2008 Jan; 17(1):61-75. PubMed ID: 18095919
[TBL] [Abstract][Full Text] [Related]
12. Risperidone.
Livingston MG
Lancet; 1994 Feb; 343(8895):457-60. PubMed ID: 7508541
[No Abstract] [Full Text] [Related]
13. Safety profile of iloperidone in the treatment of schizophrenia.
Dargani NV; Malhotra AK
Expert Opin Drug Saf; 2014 Feb; 13(2):241-6. PubMed ID: 24206391
[TBL] [Abstract][Full Text] [Related]
14. Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
Volpi S; Potkin SG; Malhotra AK; Licamele L; Lavedan C
J Clin Psychiatry; 2009 Jun; 70(6):801-9. PubMed ID: 19573479
[TBL] [Abstract][Full Text] [Related]
15. Three cases of schizophrenia showing improvement after switching to blonanserin.
Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H
Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816
[No Abstract] [Full Text] [Related]
16. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
17. Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
Bobo WV
Expert Rev Clin Pharmacol; 2013 Jan; 6(1):61-91. PubMed ID: 23272794
[TBL] [Abstract][Full Text] [Related]
18. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
[TBL] [Abstract][Full Text] [Related]
19. Risperidone: integrating research and practice.
Addington D
Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
